GLP-1-Based Therapies Have No Microvascular Effects in Type 2 Diabetes Mellitus: An Acute and 12-Week Randomized, Double-Blind, Placebo-Controlled Trial

Mark M. Smits; Lennart Tonneijck; Marcel H. A. Muskiet; Trynke Hoekstra; Mark H. H. Kramer; Michaela Diamant; Erik H. Serne; Daniel H. van Raalte

doi:https://doi.org/10.1161/ATVBAHA.116.307930

GLP-1-Based Therapies Have No Microvascular Effects in Type 2 Diabetes Mellitus: An Acute and 12-Week Randomized, Double-Blind, Placebo-Controlled Trial

Mark M. Smits, Lennart Tonneijck, Marcel H. A. Muskiet, Trynke Hoekstra, Mark H. H. Kramer, Michaela Diamant, Erik H. Serne, Daniel H. van Raalte

Research output: Contribution to journal › Article › Academic › peer-review

24 Citations (Scopus)

Original language	English
Pages (from-to)	2125-2132
Journal	Arteriosclerosis, Thrombosis, and Vascular Biology
Volume	36
Issue number	10
DOIs	https://doi.org/10.1161/ATVBAHA.116.307930
Publication status	Published - Oct 2016

Keywords

DPP-4 inhibitors
GLP-1 receptor agonists
blood pressure
diabetes mellitus
microcirculation

Access to Document

https://doi.org/10.1161/ATVBAHA.116.307930

Cite this

Smits, M. M., Tonneijck, L., Muskiet, M. H. A., Hoekstra, T., Kramer, M. H. H., Diamant, M., Serne, E. H., & van Raalte, D. H. (2016). GLP-1-Based Therapies Have No Microvascular Effects in Type 2 Diabetes Mellitus: An Acute and 12-Week Randomized, Double-Blind, Placebo-Controlled Trial. Arteriosclerosis, Thrombosis, and Vascular Biology, 36(10), 2125-2132. https://doi.org/10.1161/ATVBAHA.116.307930

@article{29563af588de4c6983ed16b4546f1f29,

title = "GLP-1-Based Therapies Have No Microvascular Effects in Type 2 Diabetes Mellitus: An Acute and 12-Week Randomized, Double-Blind, Placebo-Controlled Trial",

keywords = "DPP-4 inhibitors, GLP-1 receptor agonists, blood pressure, diabetes mellitus, microcirculation",

author = "Smits, {Mark M.} and Lennart Tonneijck and Muskiet, {Marcel H. A.} and Trynke Hoekstra and Kramer, {Mark H. H.} and Michaela Diamant and Serne, {Erik H.} and {van Raalte}, {Daniel H.}",

year = "2016",

month = oct,

doi = "https://doi.org/10.1161/ATVBAHA.116.307930",

language = "English",

volume = "36",

pages = "2125--2132",

journal = "Arteriosclerosis, Thrombosis, and Vascular Biology",

issn = "1079-5642",

publisher = "Lippincott Williams & Wilkins",

number = "10",

}

Smits, MM , Tonneijck, L , Muskiet, MHA , Hoekstra, T , Kramer, MHH, Diamant, M, Serne, EH & van Raalte, DH 2016, 'GLP-1-Based Therapies Have No Microvascular Effects in Type 2 Diabetes Mellitus: An Acute and 12-Week Randomized, Double-Blind, Placebo-Controlled Trial', Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 36, no. 10, pp. 2125-2132. https://doi.org/10.1161/ATVBAHA.116.307930

GLP-1-Based Therapies Have No Microvascular Effects in Type 2 Diabetes Mellitus: An Acute and 12-Week Randomized, Double-Blind, Placebo-Controlled Trial. / Smits, Mark M.; Tonneijck, Lennart ; Muskiet, Marcel H. A. et al.
In: Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 36, No. 10, 10.2016, p. 2125-2132.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - GLP-1-Based Therapies Have No Microvascular Effects in Type 2 Diabetes Mellitus: An Acute and 12-Week Randomized, Double-Blind, Placebo-Controlled Trial

AU - Smits, Mark M.

AU - Tonneijck, Lennart

AU - Muskiet, Marcel H. A.

AU - Hoekstra, Trynke

AU - Kramer, Mark H. H.

AU - Diamant, Michaela

AU - Serne, Erik H.

AU - van Raalte, Daniel H.

PY - 2016/10

Y1 - 2016/10

KW - DPP-4 inhibitors

KW - GLP-1 receptor agonists

KW - blood pressure

KW - diabetes mellitus

KW - microcirculation

U2 - https://doi.org/10.1161/ATVBAHA.116.307930

DO - https://doi.org/10.1161/ATVBAHA.116.307930

M3 - Article

C2 - 27562916

SN - 1079-5642

VL - 36

SP - 2125

EP - 2132

JO - Arteriosclerosis, Thrombosis, and Vascular Biology

JF - Arteriosclerosis, Thrombosis, and Vascular Biology

IS - 10

ER -